Theoretically, continuous intravenous administration of beta-lactam an
tibiotics has advantages over intermittent administration because of t
he close relationship between efficacy and the time the plasma concent
ration remains above the minimal inhibitory concentration that has bee
n found in vitro. The aim of the present study was to establish the ph
armacokinetic parameters of benzylpenicillin and cloxacillin administr
ation in patients receiving high-dose benzylpenicillin or cloxacillin
therapy by continuous infusion. A major part of the interindividual va
riation in the plasma concentrations at steady-state was attributable
to variation in renal function, as estimated by the creatinine clearan
ce. On the basis of these results, a nomogram was constructed that can
be used to determine on an individualized basis the total daily dose
of benzylpenicillin or cloxacillin necessary for each patient to obtai
n therapeutic plasma concentrations.